Dictyostelium Mechanics Accurately Identifies New Targetable Drug Space for Pancreatic Cancer Delineated by Myosin IIS, Filamins, and Alpha-Actinins, Collectively Comprimising the Mechanobiome

Biophysical Journal - United States
doi 10.1016/j.bpj.2016.11.1829
Full Text
Abstract

Available in full text

Categories
Biophysics
Date
Authors
Publisher

Elsevier BV

Related search

Inhibition of Human Pancreatic Alpha-Amylase by Montbretin A: A New Drug for Diabetes and Obesity?

Acta Crystallographica Section A Foundations of Crystallography
2008English

Expression and Characterization of Full Length Nonmuscle Myosin IIs

Biophysical Journal
Biophysics
2011English

Minnelide, a Novel Drug for Pancreatic and Liver Cancer

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2015English

Colorectal Cancer Genetic Heterogeneity Delineated by Multi-Region Sequencing

PLoS ONE
Multidisciplinary
2016English

Blebbistatin and Blebbistatin-Inactivated Myosin II Inhibit Myosin II-independent Processes in Dictyostelium

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

PRIMARY PEPTIDE SEQUENCES FROM SQUID MUSCLE AND OPTIC LOBE MYOSIN IIs: A STRATEGY TO IDENTIFY AN ORGANELLE MYOSIN

Cell Biology International
MedicineCell Biology
1998English

SF3A1 and Pancreatic Cancer: New Evidence for the Association of the Spliceosome and Cancer

Oncotarget
Oncology
2015English

The Distribution of Myosin II in Dictyostelium Discoideum Slug Cells

Journal of Cell Biology
MedicineCell Biology
1991English

Comparing Human Pancreatic Cell Secretomes by in Vitro Aptamer Selection Identifies Cyclophilin B as a Candidate Pancreatic Cancer Biomarker

Journal of Clinical Investigation
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy